Takeda Pharmaceutical Company Limited (TYO:4502)
Japan · Delayed Price · Currency is JPY 4,537.00
-26.00 (-0.57%)
Aug 21, 2025, 2:45 PM JST
Takeda Pharmaceutical Company Employees
Takeda Pharmaceutical Company had 47,455 employees as of March 31, 2025. The number of employees decreased by 1,826 or -3.71% compared to the previous year.
Employees
47,455
Change (1Y)
-1,826
Growth (1Y)
-3.71%
Revenue / Employee
94.41M JPY
Profits / Employee
2.89M JPY
Market Cap
7,127.38B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 47,455 | -1,826 | -3.71% |
| Mar 31, 2024 | 49,281 | 186 | 0.38% |
| Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
| Mar 31, 2022 | 47,347 | 248 | 0.53% |
| Mar 31, 2021 | 47,099 | -396 | -0.83% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Chugai Pharmaceutical | 5,026 |
| Daiichi Sankyo Company | 19,765 |
| HOYA Corporation | 37,909 |
| Otsuka Holdings | 35,338 |
| Astellas Pharma | 13,643 |
| Shionogi & | 4,955 |
| Olympus | 29,297 |
| M3, Inc. | 15,360 |
Takeda Pharmaceutical Company News
- 13 days ago - Cosmo and Takeda Renew Strategic Manufacturing Agreement for Global Supply of Oral Treatment for Ulcerative Colitis - Newsfile Corp
- 21 days ago - Takeda Pharma Maintains Outlook Even As Vyvanse Generics Hit Sales - Benzinga
- 21 days ago - Takeda Pharma Maintains Outlook Even As Vyvanse Generics Hit Sales - Benzinga
- 21 days ago - Takeda Pharmaceutical Company Limited (TAK) Q1 FY2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Takeda Pharmaceutical Non-GAAP EPS of ¥151.00, revenue of ¥1106.7B; reaffirms FY outlook - Seeking Alpha
- 21 days ago - Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression - Business Wire
- 22 days ago - Insights Ahead: Takeda Pharmaceutical's Quarterly Earnings - Benzinga
- 4 weeks ago - Takeda Receives FDA 510(k) Clearance for HyHubTM and HyHubTM Duo Devices to Simplify HYQVIA® Administration - Business Wire